US 11826315
STAT3 inhibitors
granted A61KA61K31/18A61P
Quick answer
US patent 11826315 (STAT3 inhibitors) held by Tvardi Therapeutics, Inc. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tvardi Therapeutics, Inc.
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/18, A61P, A61P11/00, A61P25/00